European Society for Medical Oncology (ESMO)
Recent meetings
| Date | Commissioner / Cabinet | Topic | File |
|---|---|---|---|
| 14 May 2025 | Annukka Ojala Cabinet member | Shortages of healthcare workers | — |
| 14 May 2025 | Annukka Ojala Cabinet member | Shortages of healthcare workers | SRC |
| 30 Jan 2025 | Fulvia Raffaelli Head of Unit | To discuss the European Health Data Space (EHDS) | — |
| 30 Jan 2025 | Fulvia Raffaelli Head of Unit | To discuss the European Health Data Space (EHDS) | SRC |
| 09 Apr 2024 | Tove Ernst Cabinet member | Europe’s Beating Cancer Plan; quality of life | — |
| 09 Apr 2024 | Tove Ernst Cabinet member | Europe’s Beating Cancer Plan; quality of life | SRC |
| 26 May 2020 | Stella Kyriakides Commissioner | VC meeting to discuss the EU's Cancer Plan and its objectives, cancer care and treatment during the COVID-19 pandemic | — |
| 26 May 2020 | Stella Kyriakides Commissioner | VC meeting to discuss the EU's Cancer Plan and its objectives, cancer care and treatment during the COVID-19 pandemic | SRC |
| 21 Jan 2020 | Tove Ernst Cabinet member | Discussion on cancer | — |
| 21 Jan 2020 | Tove Ernst Cabinet member | Discussion on cancer | SRC |
| 03 May 2018 | Vytenis Andriukaitis Commissioner | HTA | — |
| 03 May 2018 | Vytenis Andriukaitis Commissioner | HTA | SRC |
Mission & Goals
ESMO is the European Society for Medical Oncology. Representing over 50,000 members globally, ESMO is a reference for oncology education and information. ESMO’s core mission is to improve the quality of cancer care, from prevention and diagnosis all the way to palliative care and patient follow-up. It is to educate - doctors, patients with cancer and the general public - on the best practices and latest advances in oncology. And it is to promote equal access to optimal cancer care for all patients.
EU Legislative Interests
EU policy fields of interest for ESMO include Health, Cancer, Chronic Diseases, Public Health, Research and Innovation, Cross Border Health Care, Health Technology Assessment, Data Protection, Clinical Trials, Digitalisation, EU's Pharmaceuticals Legislation, Orphan and Paediatric Medicines, European Biotech Act, Rare Diseases, Patients' Rights, Occupational Health, Environment/Air Quality, Medical Workforce.
Communication Activities
ESMO engages frequently with the 3 main institutions of the EU - the European Commission, Parliament and Council - concerning the development of EU policies relevant for the medical oncology space. The Society - on an ongoing basis - shares its views on EU legislative proposals and processes through individual meetings with EU officials, position statements, social media campaigns, recommended amendments to EU legislation, and letters setting out the position of the Society.
Interests Represented
Promotes their own interests or the collective interests of their members
Member Of
ESMO is a full member of the Union of International Cancer Control (UICC, Geneva) and the European Health Alliance on Alcohol (EHAA). ESMO is an associate member of the NCD Alliance. ESMO has 'Official Relations Status' with the World Health Organization (WHO) and 'Special Consultative Status' with the United Nations Economic and Social Council (ECOSOC).
Organisation Members
ESMO only has individual members.